rs770340766
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS2BP4
This summary comes from the ClinGen Evidence Repository: The p.Lys412Glu variant in CDKL5 is present in 1 XY individual in gnomAD (0.0001707%) (not sufficient to meet BS1 criteria). The p.Lys412Glu variant is observed in at least 2 unaffected individuals (internal database - GeneDx) (BS2). Computational analysis prediction tools suggests that the p.Lys412Glu variant does not have a deleterious impact (BP4); however this information does not predict clinical significance on its own. In summary, the p.Lys412Glu variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS2, BP4). LINK:https://erepo.genome.network/evrepo/ui/classification/CA10360368/MONDO:0100039/034
Frequency
Consequence
NM_003159.3 missense
Scores
Clinical Significance
Conservation
Publications
- CDKL5 disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 2Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- precocious pubertyInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003159.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDKL5 | NM_001323289.2 | MANE Select | c.1234A>G | p.Lys412Glu | missense | Exon 12 of 18 | NP_001310218.1 | ||
| CDKL5 | NM_001037343.2 | c.1234A>G | p.Lys412Glu | missense | Exon 13 of 22 | NP_001032420.1 | |||
| CDKL5 | NM_003159.3 | c.1234A>G | p.Lys412Glu | missense | Exon 12 of 21 | NP_003150.1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDKL5 | ENST00000623535.2 | TSL:1 MANE Select | c.1234A>G | p.Lys412Glu | missense | Exon 12 of 18 | ENSP00000485244.1 | ||
| CDKL5 | ENST00000379989.6 | TSL:1 | c.1234A>G | p.Lys412Glu | missense | Exon 13 of 22 | ENSP00000369325.3 | ||
| CDKL5 | ENST00000379996.7 | TSL:1 | c.1234A>G | p.Lys412Glu | missense | Exon 12 of 21 | ENSP00000369332.3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD2 exomes AF: 0.00000546 AC: 1AN: 183091 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1098157Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 1AN XY: 363513 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 23
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at